Results for the period ended 31 December 2025

AI SummaryClose X

Vulcan Two Group plc reported a pre-tax loss of £1.22 million for the period ending December 31, 2025, during which it operated as a cash shell following a £12 million AIM IPO in September 2025, ending the period with £9.55 million in cash. Significant progress has been made since year-end, including a £40 million institutional placing in March 2026 and the transformational acquisition of three ePharmacy businesses, CloudRx, Webmed, and Hyperdrug, for up to approximately £41.7 million. These acquired businesses generated combined unaudited revenue of approximately £35.7 million in the 12 months to December 2025, creating a diversified platform. The company has also secured a new distribution centre and implemented an ERP system to support integration and future growth.

Disclaimer*

UK 100

Latest directors dealings